Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges

Watch this Webcast and download the slides from a CCO symposium at the 2019 CHEST Annual Meeting featuring experts in medical oncology radiation oncology and pulmonology discussing optimal integration of immune checkpoint inhibitors into the treatment of stage III NSCLC using a multidisciplinary approach.

Share

Program Content

Activities

Stage III NSCLC Overview
Overview of Stage III NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 21, 2019

Expires: October 19, 2020

ICI Therapy for Stage III NSCLC
Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 21, 2019

Expires: October 19, 2020

Stage III NSCLC Patient Cases
Case Discussions on Optimal Integration of Checkpoint Inhibitors Into the Management of Stage III NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 21, 2019

Expires: October 19, 2020

Activities

Optimizing Stage III NSCLC Care
Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2019

Expires: November 18, 2020

Faculty

cover img faculity

Kristin Higgins, MD

Medical Director
Associate Professor

Department of Radiation Oncology
Emory University
Atlanta, Georgia

cover img faculity

Gerard A. Silvestri, MD, MS

Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Medical University of South Carolina
Charleston, South Carolina

cover img faculity

Mark A. Socinski, MD

Director, Lung Cancer Section of the Division of Hematology/Oncology
Co-Director, UPMC Center for Excellence in Lung Cancer
Co-Director, Lung and Thoracic Malignancies Program
University of Pittsburgh Cancer Institute
University of Pittsburgh
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca